Join the #BlueBalloonChallenge to raise diabetes awareness
Blue Balloon Challenge
This year, as we honor caregivers and parents of people living with diabetes, we’re proud to share a powerful testimonial from Irina Zvereva, mother of tennis champion Alexander Zverev, who has lived with type 1 diabetes since the age of four.
As Irina beautifully puts it: “Anything is possible with type 1 diabetes”
In opening up about her son’s journey, Irina echoes the Blue Balloon’s metaphor:
Living with type 1 diabetes is like doing everything you do in your daily life, while keeping a balloon in the air. It's a constant balancing act.
The Zverev story is a powerful reminder that greatness can rise from challenges.
Once again this year, we’re proud to support Life for a Child through our #BlueBalloonChallenge, helping children in under-resourced countries gain access to essential diabetes care.
Join the #BlueBalloonChallenge to raise diabetes awareness
It’s called MiniMed™ 780G and it has improved my quality of life tremendously.
Nicole
MiniMed™ 780G system user
Our Therapies
Insulin Pump Therapies
MiniMed 780G™ System
Automated for an easier way to stabilise glucose levels.
Fewer injections vs
- #Multiple Daily Injections (3 bolus and 1 basal insulin per day) requires 28 injections per week vs. one infusion set change every two to three days.
Helps to reach 80% Time in
Multiple Daily Injection Therapies
What is a Smart MDI System?
This first-in-the-world Smart MDI system combines Guardian™ 4
We’ve developed a robust portfolio of life-transforming technologies that leverage data to deliver personalised insights, so you can take on each day with confidence.
With our comprehensive, flexible offerings, our empathetic service and support, you can live fully in the moment. We’re working to help you manage your type 1 diabetes, your way.
- Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- 1.Medtronic data on file: MiniMed ™ 780G data uploaded voluntarily by 12.870 users in EMEA to CareLink™ Personal, from 27 August 2020 to 22 July 2021. Mean 80% TIR reached by 1.784 users using MiniMed ™ 780G with recommended settings of 2 hours active insulin time and 100 mg/dL (5.5 mmol/L) as glucose target for at least 90% of the time.
- * Smart CGM predicts future high and low sensor glucose events up to 1 hour in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns. Please refer to IFU.
- ** Smart Insulin pen connects to a mobile app to provide dosing calculations, reminders and CGM system integration. Please refer to IFU.